Acorda CEO Cohen on U.S. Budget Cuts, Research

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

March 22 (Bloomberg) -- Ron Cohen, chief executive officer of Acorda Therapeutics Inc., talks about the impact of U.S. budget cuts on medical research and drug development. Cohen, speaking with Sara Eisen and Tom Keene on Bloomberg Television's "Surveillance," also discusses China's investment in medical care and science. (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change